NGS Analysis of Heterogeneous Retinitis Pigmentosa

One of the most significant milestones in biomedical research was the completion of the human genome sequencing project. The subsequent invention of Next-Generation Sequencing (NGS) technology has revolutionized molecular biology, genetics, and genomics. Already, medicine is being tailored to take into account an individual’s genome. In particular, diseases with diverse genetic causes, such as retinitis pigmentosa (RP), are poised for the clinical use of NGS.